Best known as the company that launched the world’s first “antibody biosimilar,” Celltrion is looking to continue its growth as a global…

Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to base the company in Switzerland, its…

Korean biosimilar firm Celltrion's USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant moment…